IDRSF

$7.75-$0.15 (-1.90%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$3.30 – $8.19

91% from low

Exchange

OTC Link

Change$-13.14

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$207M	-2.6%	$-0.57	$-0.63–$-0.52	—	1
2027	$270M	+30.9%	$-0.28	$-0.31–$-0.26	—	1
2028	$349M	+29.2%	$0.07	$0.06–$0.07	115.8×	1
2029	$430M	+23.2%	$0.04	$0.04–$0.04	194.2×	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Beat consensus in 6 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-07-30	$-0.24	$-0.20	+15.4%
2026-04-28	$-0.23	$-0.18	+24.3%
2026-02-26	$-0.25	$-0.34	-38.5%
2025-10-30	$-0.28	$-0.35	-25.0%
2025-07-30	$-0.25	$-0.08	+69.8%
2025-04-30	$-0.29	$0.39	+234.0%
2025-03-04	$-0.62	$-0.49	+20.3%
2024-10-29	$-0.63

Symbol	Price	Today	Mkt cap	P/E
IDRSFIdorsia Ltd	$7.90	+13.67%	$2.0B	—
ARRJFArjo AB (publ)	$2.92	+0.00%	$795M	—
ASCLFAscletis Pharma Inc.	$1.21	+0.00%	$1.3B	—
BPMUFBasilea Pharmaceutica AG	$65.50	+0.00%	$811M	—
INRLFValneva SE	$2.43	+0.00%

No one on the platform currently holds IDRSF.

Institutions holding (13F)

No tracked institution reports a position in IDRSF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

No one on the platform has traded IDRSF yet.

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.